VEXAS Anemia is a Mosaic Erythroblastopenia: A New Publication from Hermine Laboratory
Hermine Laboratory shared on LinkedIn:
”New Publication Alert
We’re excited to share our latest study: “VEXAS syndrome Anemia Is a Mosaic Erythroblastopenia” published in Blood Journal (Rodrigues F. et al., Blood, 2025)
In this work, we reveal that VEXAS-associated anemia is driven by a selective failure of erythroid precursor maturation — the first clear evidence that the condition represents a mosaic erythroblastopenia rather than a uniform red-cell defect.
Key findings include:
• Patient bone-marrow erythroblasts with UBA1 mutations showed lethal early differentiation arrest in edited CD34⁺ cells, mirroring features of other ribosomopathies.
Why it matters
This study advances our mechanistic understanding of VEXAS anemia and offers clues toward potential treatment strategies that focus on restoring healthy erythropoiesis.
We hope this will spark new translational opportunities in the field of hematologic disorders.
Thank you to all our collaborators, patients, and funders who made this work possible.”
Read the full article in Blood.
Article: VEXAS anemia is a mosaic erythroblastopenia
Authors: Francois Rodrigues Corresponding Author , Giulia Hardouin, Sara El Hoss, Aya Ghoul, Emilie-Fleur Gautier, Michaël Dussiot, Maria A. Lizarralde-Iragorri, Annalisa Santini, Sandy Peltier, Pascal Amireault, Vanessa Soldan, Annarita Miccio, Mounia Debili, Vincent Jachiet, Thiago Trovati Maciel, Julien Rossignol, Eric Allemand, Arsène M Mékinian, Sophie Anne Georgin-Lavialle, Pr, Mohammad Salma, Eric Soler, Pierre-Emmanuel Gleizes, Marie-Francoise O’Donohue, Olivier Kosmider, Manuel S. Rodriguez, Olivier Hermine
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia
-
Oct 9, 2026, 12:48Santiago Cepeda Chafla: CereBleed Simplifies Brain Hemorrhage Assessment
-
Oct 9, 2026, 12:34Abdul Muqtadir Abbasi: Pancytopenia Is a Finding, Not a Diagnosis
-
Oct 9, 2026, 12:24Mercy Lung’aho: When Diet Quality and Nutritional Biomarkers Tell Different Stories
-
Oct 9, 2026, 12:22Eugene Fan: Bridging Therapeutic Breakthroughs and Equitable Thalassaemia Care